[Drug therapy in urinary calculi. II. Peroral litholysis and prevention].
D000284:Administration, Oral; D000493:Allopurinol / Q000008:administration & dosage / Q000627:therapeutic use; D003553:Cystine / Q000378:metabolism; D006801:Humans; D008274:Magnesium / Q000008:administration & dosage / Q000627:therapeutic use; D010070:Oxalates / Q000378:metabolism; D010396:Penicillamine / Q000008:administration & dosage / Q000627:therapeutic use; D010710:Phosphates / Q000378:metabolism; D011736:Pyridoxine / Q000008:administration & dosage / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000378:metabolism; D014545:Urinary Calculi / Q000188:drug therapy* / Q000517:prevention & control
D010070:Oxalates; D010710:Phosphates; D000644:Quaternary Ammonium Compounds; D003553:Cystine; D000493:Allopurinol; D010396:Penicillamine; D008274:Magnesium; D011736:Pyridoxine
Die medikamentöse Behandlung des Harnsteinleidens. II. Perorale Litholyse und Prophylaxe.